Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.
暂无分享,去创建一个
A. Zauber | B. Hankey | W. Shi | M. van Ballegooijen | I. Lansdorp-Vogelaar | S. Winawer | M. O'brien | J. Waye | M. Schapiro | J. Bond | J. Panish | E. Stewart
[1] Harminder Singh,et al. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. , 2006, JAMA.
[2] D. Lieberman. A call to action--measuring the quality of colonoscopy. , 2006, The New England journal of medicine.
[3] A. Jemal,et al. Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates , 2010, Cancer.
[4] D. Ransohoff,et al. How Much Does Colonoscopy Reduce Colon Cancer Mortality? , 2009, Annals of Internal Medicine.
[5] J. Faivre,et al. Estimation of screening test (Hemoccult®) sensitivity in colorectal cancer mass screening , 2001, British Journal of Cancer.
[6] Robert H Fletcher,et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. , 2006, CA: a cancer journal for clinicians.
[7] S. Moss,et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.
[8] E T Stewart,et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. , 1993, The New England journal of medicine.
[9] Marcin Polkowski,et al. Quality indicators for colonoscopy and the risk of interval cancer. , 2010, The New England journal of medicine.
[10] D. Ransohoff,et al. Five-Year risk of colorectal neoplasia after negative screening colonoscopy , 2008, Acta Endoscopica.
[11] H. Brenner,et al. Protection from colorectal cancer after colonoscopy: Population-based case-control study , 2010 .
[12] Charles J. Kahi,et al. Effect of screening colonoscopy on colorectal cancer incidence and mortality. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[13] L M Schuman,et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.
[14] J. Church,et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer , 2002, American Journal of Gastroenterology.
[15] M. Diebold,et al. [Management of malignant polyps]. , 1998, Gastroenterologie clinique et biologique.
[16] T. Church,et al. Colorectal cancer deaths as determined by expert committee and from death certificate: a comparison. The Minnesota Study. , 1999, Journal of clinical epidemiology.
[17] Jane Wardle,et al. Wide variation in adenoma detection rates at screening flexible sigmoidoscopy. , 2004, Gastroenterology.
[18] A. Zauber,et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. , 1993 .
[19] D. Gyrd-Hansen,et al. Analysis of screening data: colorectal cancer. , 1997, International journal of epidemiology.
[20] P. Simpson,et al. Statistical methods in cancer research , 2001, Journal of surgical oncology.
[21] E. Feuer,et al. A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer. , 1994, Journal of clinical epidemiology.
[22] Deborah Schrag,et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. , 2005, Journal of the National Cancer Institute.
[23] L. Rabeneck,et al. Endoscopist specialty is associated with incident colorectal cancer after a negative colonoscopy. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[24] A. Zauber,et al. High-quality colonoscopies must be an integral part of screening and surveillance programs. , 2006, Gastroenterology.
[25] E. Kliewer,et al. The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. , 2010, Gastroenterology.
[26] A. Neugut,et al. Colonoscopy vs sigmoidoscopy screening: getting it right. , 2010, JAMA.
[27] P. Allen,et al. Studying cancer in minorities , 2011, Cancer.
[28] R. Pearson. Low Risk of Colorectal Cancer and Advanced Adenomas More Than 10 Years After Negative Colonoscopy , 2010 .
[29] P. Rothwell,et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials , 2011, The Lancet.
[30] J. Meyerhardt,et al. Aspirin dose and duration of use and risk of colorectal cancer in men. , 2008, Gastroenterology.
[31] A. Algra,et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials , 2010, The Lancet.
[32] Tim Byers,et al. Colorectal cancer in patients under close colonoscopic surveillance. , 2005, Gastroenterology.
[33] D. Ransohoff,et al. Adverse Events After Outpatient Colonoscopy in the Medicare Population , 2009, Annals of Internal Medicine.
[34] Jahn M. Nesland,et al. Morphologic Reappraisal of Serrated Colorectal Polyps , 2003, The American journal of surgical pathology.
[35] Deborah Schrag,et al. How much can current interventions reduce colorectal cancer mortality in the U.S.? , 2006, Cancer.
[36] A. Schatzkin,et al. Colonoscopic screening of average-risk women for colorectal neoplasia. , 2005, The New England journal of medicine.
[37] J. Reguła,et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. , 2006, The New England journal of medicine.
[38] W. Chiong. Equipoise and the dilemma of randomized clinical trials. , 2011, The New England journal of medicine.
[39] P. Rothwell,et al. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies , 2007, The Lancet.
[40] Dawn Provenzale,et al. Five-year colon surveillance after screening colonoscopy. , 2007, Gastroenterology.
[41] B. Levin,et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. , 2008, Gastroenterology.
[42] A. Zauber,et al. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. , 1990, Gastroenterology.
[43] Ennis,et al. Correction: Use of Colonoscopy to Screen Asymptomatic Adults for Colorectal Cancer. , 2000, The New England journal of medicine.
[44] O. Kronborg,et al. Influence of long-term colonoscopic surveillance on incidence of colorectal cancer and death from the disease in patients with precursors (adenomas) , 2007, Acta oncologica.
[45] R. Sandler. Editorial: Colonoscopy and Colorectal Cancer Mortality: Strong Beliefs or Strong Facts? , 2010, The American Journal of Gastroenterology.
[46] L. Rabeneck,et al. Association of Colonoscopy and Death From Colorectal Cancer , 2009, Annals of Internal Medicine.
[47] S. Duffy,et al. Estimating sensitivity and sojourn time in screening for colorectal cancer: a comparison of statistical approaches. , 1998, American journal of epidemiology.
[48] J. Olsen,et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.
[49] M. Bretthauer. The capsule and colorectal-cancer screening--the crux of the matter. , 2009, The New England journal of medicine.
[50] A. Zauber,et al. The national polyp study design, methods, and characteristics of patients with newly diagnosed polyps , 1992, Cancer.
[51] S. Duffy,et al. Colorectal cancer mass‐screening: Estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time , 1997, International journal of cancer.